Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Hall

Showing results (661-670 of 1,784) with videos related to

Pageof 179
Sort By:
Anticancer Research|August 11, 2001
Cytotoxicity and mode of action of 1-(1-cyclohexenyl) and 1-unsubstituted 3,5-pyrazolidinediones in human Molt4 T cell leukemiaB J Barnes, R A Izydore, I H Hall
Journal of Pharmaceutical Sciences|February 1, 1984
Antineoplastic activity of tetrakis-mu-(trimethylamine-boranecarboxylato)-bis (trimethylamine-carboxyborane)dicopper (II) in Ehrlich ascites carcinomaI H Hall, B F Spielvogel, A T McPhail
Anti-Cancer Drugs|December 1, 1993
The cytotoxicity of N-substituted diphenimides and 6,7-dihydro-5H-dibenz[c,e]azepinesI H Hall, O T Wong, L K Chi
Acta Geneticae Medicae Et Gemellologiae|January 1, 1979
Anaemia in twin pregnancyM H Hall, D M Campbell, R J Davidson
Bulletin of Environmental Contamination and Toxicology|March 1, 1982
Structure-toxicity relationships of selected nitrogenous heterocyclic compounds. III. Relations using molecular connectivityT W Schultz, L B Kier, L H Hall
The American Psychologist|November 6, 2018
Sleep and cardiovascular disease: Emerging opportunities for psychologyMartica H Hall, Ryan C Brindle, Daniel J Buysse
Journal of Pharmaceutical Sciences|June 1, 1982
Antitumor agents LII: The effects of molephantinin on nucleic acid and protein synthesis of Ehrlich ascites cellsI H Hall, Y F Liou, K H Lee
Journal of Pharmaceutical Sciences|January 1, 1981
Antifertility activity of N-protected glycine activated estersJ H Drew, L J Loeffler, I H Hall
Prenatal Diagnosis|May 22, 2001
Transitory unilateral pleural effusion associated with mosaic Turner's syndromeG H Hall, M J Weston, D J Campbell
Canadian Journal of Biochemistry|January 1, 1975
3-Methyl-2-butenal: an enzymatic degradation product of the cytokinin, N-6-(delta-2 isopentenyl)adenineB G Brownlee, R H Hall, C D Whitty
Pageof 179

Showing results (661-670 of 1,784) with videos related to

Sort By:
Pageof 179
Anticancer Research|August 11, 2001
Cytotoxicity and mode of action of 1-(1-cyclohexenyl) and 1-unsubstituted 3,5-pyrazolidinediones in human Molt4 T cell leukemiaB J Barnes, R A Izydore, I H Hall
Journal of Pharmaceutical Sciences|February 1, 1984
Antineoplastic activity of tetrakis-mu-(trimethylamine-boranecarboxylato)-bis (trimethylamine-carboxyborane)dicopper (II) in Ehrlich ascites carcinomaI H Hall, B F Spielvogel, A T McPhail
Anti-Cancer Drugs|December 1, 1993
The cytotoxicity of N-substituted diphenimides and 6,7-dihydro-5H-dibenz[c,e]azepinesI H Hall, O T Wong, L K Chi
Acta Geneticae Medicae Et Gemellologiae|January 1, 1979
Anaemia in twin pregnancyM H Hall, D M Campbell, R J Davidson
Bulletin of Environmental Contamination and Toxicology|March 1, 1982
Structure-toxicity relationships of selected nitrogenous heterocyclic compounds. III. Relations using molecular connectivityT W Schultz, L B Kier, L H Hall
The American Psychologist|November 6, 2018
Sleep and cardiovascular disease: Emerging opportunities for psychologyMartica H Hall, Ryan C Brindle, Daniel J Buysse
Journal of Pharmaceutical Sciences|June 1, 1982
Antitumor agents LII: The effects of molephantinin on nucleic acid and protein synthesis of Ehrlich ascites cellsI H Hall, Y F Liou, K H Lee
Journal of Pharmaceutical Sciences|January 1, 1981
Antifertility activity of N-protected glycine activated estersJ H Drew, L J Loeffler, I H Hall
Prenatal Diagnosis|May 22, 2001
Transitory unilateral pleural effusion associated with mosaic Turner's syndromeG H Hall, M J Weston, D J Campbell
Canadian Journal of Biochemistry|January 1, 1975
3-Methyl-2-butenal: an enzymatic degradation product of the cytokinin, N-6-(delta-2 isopentenyl)adenineB G Brownlee, R H Hall, C D Whitty
Pageof 179